BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Wednesday, April 24, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
March 7, 2007
View Archived Issues
Shire rounds up 2006 highlights
Read More
Recent patents describe new therapeutic agents for endocrine-related disorders
Read More
Novel treatment options for metabolic disorders described in recent patents
Read More
AVE-8062 causes necrosis and reduces metabolic activity in ovarian tumors
Read More
HMMC-1 reduces lymph node tumor burden
Read More
Novel therapeutic agents for infectious diseases disclosed in recent patent literature
Read More
CDC study validates Lovaxin C treatable population
Read More
Positive data reported for TRA-8/cisplatin combo in a model of cervical cancer
Read More
Aker BioMarine and Pronova to establish new company
Read More
AD-923 begins U.S. phase I development for cancer breakthrough pain
Read More
GSK's prepandemic vaccine protects against different strains of H5N1
Read More
APD-125 begins phase II for insomnia
Read More
Lilly to acquire Hypnion
Read More
New company Calistoga closes Series A financing
Read More
Cerus receives grants to develop vaccines based on Listeria platforms
Read More
Positive findings from first stage of phase II LymphoSeek trial
Read More
InterMune discontinues phase III INSPIRE trial of Actimmune in IPF
Read More
Phase III studies of ferumoxytol cleared to continue to completion
Read More
BioCryst and Shionogi collaborate on injectable peramivir in Japan
Read More
D-4F, an apoA-I mimetic, shows efficacy in asthma model
Read More
Kyowa Hakko Kogyo licenses KW-2871 to Life Science Pharmaceuticals
Read More
E1-I.N.T. reduces HbA1c levels in type 1 and type 2 diabetes
Read More
MEM-1003 shows no efficacy in bipolar mania
Read More
Significant pain relief demonstrated in phase IIb study of Fentanyl TAIFUN
Read More
Positive findings for Collegium's seasonal allergic rhinitis combination product
Read More
PHX-1149 significantly improves postprandial glucose and HbA1c levels
Read More
HMOCC-2 monoclonal antibody shows potential to treat ovarian cancer
Read More